• DOI:10.1093/JAT/32.1.68
• Corpus ID: 25775817

Quantification of nerve agent VX-butyrylcholinesterase adduct biomarker from an accidental exposure.

@article{Solano2008QuantificationON,
  title={Quantification of nerve agent VX-butyrylcholinesterase adduct biomarker from an accidental exposure.},
  author={Maria I. Solano and Jerry D. Thomas and James T Taylor and Jeffrey M. McGuire and Edward M. Jakubowski and Sandra A. Thomson and Vincent L. Maggio and Kerry E Holland and J. Richard Smith and Benedict R. Capacio and Adrian R. Woolfitt and David L. Ashley and John R. Barr},
  journal={Journal of analytical toxicology},
  year={2008},
  volume={32 1},
  pages={
          68-72
        }
}

• Maria I. Solano, Jerry D. Thomas, +10 authors J. Barr
• Published 2008
• Chemistry
• Journal of analytical toxicology

The lack of data in the open literature on human exposure to the nerve agent O-ethyl-S-(2-diisopropylaminoethyl) methylphosphonothioate (VX) gives a special relevance to the data presented in this study in which we report the quantification of VX-butyrylcholinesterase adduct from a relatively low-level accidental human exposure. The samples were analyzed by gas chromatography-high resolution mass spectrometry using the fluoride ion regeneration method for the quantification of multiple nerve agents including VX. Six human plasma samples from the same individual were collected after the patient had been treated once with oxime immediately after exhibiting signs of exposure. Detection limits of approximately 5.5 pg/mL plasma were achieved for the G-analogue of VX (G-VX). Levels of the G-VX ranged from 81.4 pg/mL on the first day after the exposure to 6.9 pg/mL in the sample taken 27 days after the exposure. Based on the reported concentration of human butyrylcholinesterase in plasma of approximately 80 nM, it can be calculated that inhibition levels of >or= 0.05% of BuChE can be accurately quantified. These data further indicate that the fluoride ion regeneration method is a potentially powerful tool that can be used to assess low-level exposure to VX.